Relative Dose Intensity of Induction-Phase Pazopanib Treatment of Soft Tissue Sarcoma: Its Relationship with Prognoses of Pazopanib Responders

The approved standard dose of pazopanib is 800 mg per day, but the appropriate dose of pazopanib to treat soft tissue sarcoma (STS) patients in real-world practice is controversial. Of 124 STS patients treated with pazopanib, we retrospectively analyzed the cases of STS patients who achieved progres...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Clin Med
Hoofdauteurs: Nakano, Kenji, Funauchi, Yuki, Hayakawa, Keiko, Tanizawa, Taisuke, Ae, Keisuke, Matsumoto, Seiichi, Takahashi, Shunji
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2019
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6352274/
https://ncbi.nlm.nih.gov/pubmed/30626115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8010060
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items